Bli medlem
Bli medlem

Du är här

2018-01-25

Vitrolife AB (publ): Redeye: Resumes analyst coverage of Vitrolife

Vitrolife is a company of high quality and significant growth
opportunities still remain. With an outstanding track record, the bar
is set high, and offers little room for disappointment. We resume
coverage with a fair value (base case) of SEK 620 per share,
indicating no upside at current levels. Read more and download the
extended Research Update by Arvid Necander: https://goo.gl/152VoX

Start following Vitrolife at Redeye to instantly receive our latest
company research.

This is a press release from Redeye - Research Powered Investment
Banking. https://www.redeye.se/about/

-----------------------------------------------------------
http://news.cision.com/se/vitrolife-ab--publ-/r/redeye--resumes-analyst-...

Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.